Private equity firms have been identifying areas with a higher prevalence of autism and investing in ASD services in those areas.

Menopause hormone therapy use does not appear to be associated with an increased risk for dementia for postmenopausal women.

The strongest factor associated with no MMR vaccination by the age of 2 appears to be late administration of the 2- and 4-month MMR vaccine.

Researchers explored risks for individual hematological malignancies among patients with vs without systemic sclerosis.

New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

Alcohol is linked to elevated risk for multiple types of cancer, particularly when consumed at higher frequencies and greater quantities.

The Brain Care Score is a tool encompassing 12 modifiable risk factors that may help measure brain health and identify stroke risk.

The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).

Compared with etomidate, use of ketamine to induce anesthesia during tracheal intubation does not result in lower in-hospital death rates.

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.

The Food and Drug Administration has approved Nereus (tradipitant) for the prevention of vomiting induced by motion in adults.

Contrast media used for medical imaging may be contributing to environmental pollution as researchers measure and consider the impact.